Marketing-authorisation holder · Netherlands
Astellas Pharma Europe B.V.
96 medicines in 5 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Netherlands
96 medicines in 5 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 96
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADVAGRAFCapsula rigida a rilascio prolungato | Tacrolimus | Italy | Authorised | |
| Advagraf | Tacrolimus | EU (EMA) | Authorised | 2007 |
| ADVAGRAF 0,5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA0,5 mg · Cápsula dura de liberación prolongada | Tacrolimus | Spain | Marketed | 2012 |
| ADVAGRAF 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA1 mg · Cápsula dura de liberación prolongada | Tacrolimus | Spain | Marketed | 2012 |
| ADVAGRAF 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA1 mg · Cápsula dura de liberación prolongada | Tacrolimus | Spain | Marketed | 2012 |
| ADVAGRAF 3 MG CAPSULAS DURAS DE LIBERACION PROLONGADA3 mg · Cápsula dura de liberación prolongada | Tacrolimus | Spain | Marketed | 2012 |
| ADVAGRAF 5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA5 mg · Cápsula dura de liberación prolongada | Tacrolimus | Spain | Marketed | 2012 |
| Betmiga | Mirabegron | EU (EMA) | Authorised | 2012 |
| BETMIGACompressa a rilascio prolungato | Mirabegron | Italy | Authorised | |
| Betmiga 25 mg, tabletten met verlengde afgifteTablet met verlengde afgifte | Mirabegron | Netherlands | Authorised | 2012 |
| Betmiga 50 mg, tabletten met verlengde afgifteTablet met verlengde afgifte | Mirabegron | Netherlands | Authorised | 2012 |
| BETMIGA 50mg comprimidos de liberacion prolongada50 mg · Comprimido de liberación prolongada | Mirabegron | Spain | Marketed | 2013 |
| Betmiga 8 mg/ml granulaat voor suspensie voor oraal gebruik met verlengde afgifteGranulaat met verlengde afgifte, Granulaat voor orale suspensie | Mirabegron | Netherlands | Authorised | 2024 |
| Evrenzo | Roxadustat | EU (EMA) | Authorised | 2021 |
| EVRENZOCompressa rivestita con film | Roxadustat | Italy | Authorised | |
| EVRENZO 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA100 mg · Comprimido recubierto con película | Roxadustat | Spain | Marketed | 2021 |
| Evrenzo 100 mg filmomhulde tablettenFilmomhulde tablet | Roxadustat | Netherlands | Authorised | 2021 |
| EVRENZO 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA150 mg · Comprimido recubierto con película | Roxadustat | Spain | Marketed | 2021 |
| Evrenzo 150 mg filmomhulde tablettenFilmomhulde tablet | Roxadustat | Netherlands | Authorised | 2021 |
| EVRENZO 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA20 mg · Comprimido recubierto con película | Roxadustat | Spain | Marketed | 2021 |
| Evrenzo 20 mg filmomhulde tablettenFilmomhulde tablet | Roxadustat | Netherlands | Authorised | 2021 |
| EVRENZO 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA50 mg · Comprimido recubierto con película | Roxadustat | Spain | Marketed | 2021 |
| Evrenzo 50 mg filmomhulde tablettenFilmomhulde tablet | Roxadustat | Netherlands | Authorised | 2021 |
| EVRENZO 70 MG COMPRIMIDOS RECUBIERTOS CON PELICULA70 mg · Comprimido recubierto con película | Roxadustat | Spain | Marketed | 2021 |
| Evrenzo 70 mg filmomhulde tablettenFilmomhulde tablet | Roxadustat | Netherlands | Authorised | 2021 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 30 | 28 | 2 | CompaniesAll medicines |
| Netherlands | 26 | 26 | 0 | CompaniesAll medicines |
| Romania | 19 | 0 | 19 | CompaniesAll medicines |
| European Union (EMA) | 12 | 9 | 3 | CompaniesAll medicines |
| Italy | 9 | 9 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.